ATE354656T1 - Von menschlichem tumor stammendes polypeptidhormon phosphatonin - Google Patents

Von menschlichem tumor stammendes polypeptidhormon phosphatonin

Info

Publication number
ATE354656T1
ATE354656T1 AT99926320T AT99926320T ATE354656T1 AT E354656 T1 ATE354656 T1 AT E354656T1 AT 99926320 T AT99926320 T AT 99926320T AT 99926320 T AT99926320 T AT 99926320T AT E354656 T1 ATE354656 T1 AT E354656T1
Authority
AT
Austria
Prior art keywords
human tumor
derived polypeptide
polypeptide hormone
phosphatonin
human protein
Prior art date
Application number
AT99926320T
Other languages
English (en)
Inventor
Peter Rowe
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9810681.8A external-priority patent/GB9810681D0/en
Application filed by Univ London filed Critical Univ London
Application granted granted Critical
Publication of ATE354656T1 publication Critical patent/ATE354656T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT99926320T 1998-05-18 1999-05-18 Von menschlichem tumor stammendes polypeptidhormon phosphatonin ATE354656T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810681.8A GB9810681D0 (en) 1998-05-18 1998-05-18 Hormone
GBGB9819387.3A GB9819387D0 (en) 1998-05-18 1998-09-04 Polypeptide

Publications (1)

Publication Number Publication Date
ATE354656T1 true ATE354656T1 (de) 2007-03-15

Family

ID=26313705

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99926320T ATE354656T1 (de) 1998-05-18 1999-05-18 Von menschlichem tumor stammendes polypeptidhormon phosphatonin

Country Status (13)

Country Link
US (6) US6818745B1 (de)
EP (1) EP1086225B1 (de)
JP (1) JP4424575B2 (de)
CN (1) CN100359015C (de)
AT (1) ATE354656T1 (de)
AU (1) AU765349B2 (de)
CA (1) CA2329054C (de)
DE (1) DE69935220T2 (de)
DK (1) DK1086225T3 (de)
ES (1) ES2281964T3 (de)
MX (1) MXPA00011272A (de)
TW (1) TWI227734B (de)
WO (1) WO1999060017A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810681D0 (en) * 1998-05-18 1998-07-15 Royal Free Hosp School Med Hormone
WO1999060017A2 (en) * 1998-05-18 1999-11-25 University College London Human tumour-derived polypeptide hormone phosphatonin
WO2001032878A2 (en) * 1999-11-04 2001-05-10 University College London A novel polypeptide hormone phosphatonin
US6790639B2 (en) * 2000-02-29 2004-09-14 Pfizer Inc. Mammalian osteoregulins
WO2001072826A2 (en) * 2000-03-24 2001-10-04 Genzyme Corporation Oncogenic osteomalacia-related gene 1
GB0008936D0 (en) * 2000-04-11 2000-05-31 Glaxo Group Ltd Vectors
US20030175808A1 (en) * 2000-06-21 2003-09-18 Tomofumi Kurokawa Novel protein and dna thereof
DE60142239D1 (de) 2000-08-11 2010-07-08 Kyowa Hakko Kirin Co Ltd DEN PHOSPHORSÄURE-METABOLISMUS, DEN KALZIUM-METABOLISMUS, VERKALKUNG UND DEN VITAMIN D-METABOLISMUS KONTROLLIERENDE POLYPEPTIDE SOWIE FüR DIESE KODIERENDE DNA-MOLEKÜLE
US6911425B2 (en) 2000-08-16 2005-06-28 Acologix, Inc. Integrin binding motif containing peptides and methods of treating skeletal diseases
DK1313440T3 (da) 2000-08-16 2008-11-03 Acologix Inc Dentalprodukter indeholdende knoglevækstforögende peptider
ATE441666T1 (de) 2001-12-28 2009-09-15 Kyowa Hakko Kirin Co Ltd Antikírper gegen den fibroblastenwachstumsfaktor 23
US7638486B2 (en) 2005-07-18 2009-12-29 Acologix, Inc. Method for promoting hard tissue formation
JP2009511426A (ja) * 2005-08-30 2009-03-19 アコロジックス インコーポレイティッド ミネラルおよび骨格代謝の調節
WO2007032559A1 (ja) * 2005-09-15 2007-03-22 Osaka University 新規モノクローナル抗体及びその用途
JPWO2007032560A1 (ja) * 2005-09-15 2009-03-19 国立大学法人大阪大学 新規モノクローナル抗体及びその用途
US7825217B2 (en) * 2006-09-15 2010-11-02 University Of Kansas Medical Center Polypeptides for bone mineralization
MX2009007693A (es) 2007-01-22 2009-08-31 Acologix Inc Composicion de peptido y metodo para promover la formacion de cartilago.
US7883705B2 (en) 2007-02-14 2011-02-08 Kyowa Hakko Kirin Co., Ltd. Anti FGF23 antibody and a pharmaceutical composition comprising the same
AU2010210600B2 (en) 2009-02-06 2016-07-14 C3 Jian, Inc. Calcium-binding agents induce hair growth and/or nail growth
BR112020015291B1 (pt) * 2018-03-19 2023-09-26 Regeneron Pharmaceuticals, Inc Tampão de amostra de eletroforese aquoso, método para identificar contaminantes ou impurezas em uma amostra de fármaco proteico, e, kit

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015628A (en) * 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
US5340934A (en) * 1989-11-03 1994-08-23 The United States Of Americas As Represented By The Secretary Of Health & Human Services CDNA sequences of human bone matrix proteins
GB9203958D0 (en) * 1992-02-25 1992-04-08 Norske Stats Oljeselskap Catalytic multi-phase reactor
EP0679716A4 (de) * 1993-11-12 1999-06-09 Kenichi Matsubara Genetische Signaturen.
US5981478A (en) 1993-11-24 1999-11-09 La Jolla Cancer Research Foundation Integrin-binding peptides
US6103709A (en) * 1993-12-23 2000-08-15 The Regents Of The University Of California Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases
US5770565A (en) * 1994-04-13 1998-06-23 La Jolla Cancer Research Center Peptides for reducing or inhibiting bone resorption
US6027592A (en) * 1995-06-06 2000-02-22 Gillette Canada Inc. Dental floss
US6300062B1 (en) * 1995-07-13 2001-10-09 Biora Ab Enamel matrix related polypeptide
US5837674A (en) * 1996-07-03 1998-11-17 Big Bear Bio, Inc. Phosphopeptides and methods of treating bone diseases
EP1003570A1 (de) 1997-08-15 2000-05-31 Children's Medical Center Corporation Osteopontinbeschichtete oberflächen und verfahren zur verwendung
US6146655A (en) * 1997-08-29 2000-11-14 Softy-Flex Inc. Flexible intra-oral bandage and drug delivery system
US6410248B1 (en) 1998-01-30 2002-06-25 Massachusetts Institute Of Technology General strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites
WO1999043844A1 (en) 1998-02-27 1999-09-02 The Trustees Of Columbia University In The City Of New York Reciprocal subtraction differential display
US6673900B2 (en) * 1999-11-04 2004-01-06 University College London Polypeptide hormone-phosphatonin
WO1999060017A2 (en) 1998-05-18 1999-11-25 University College London Human tumour-derived polypeptide hormone phosphatonin
US7098185B2 (en) * 1998-05-18 2006-08-29 University College London Polypeptide hormone phosphatonin
US6045780A (en) * 1998-06-22 2000-04-04 Shemberg Marketing Corporation Toothpaste composition
AUPP893999A0 (en) 1999-03-01 1999-03-25 Csl Limited Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
US6145655A (en) 1999-10-04 2000-11-14 Tsai; Allan Lens cleaning kit
US6790639B2 (en) * 2000-02-29 2004-09-14 Pfizer Inc. Mammalian osteoregulins
WO2001072826A2 (en) 2000-03-24 2001-10-04 Genzyme Corporation Oncogenic osteomalacia-related gene 1
CN100350971C (zh) 2000-07-19 2007-11-28 奥索洛吉艾斯有限公司 用凝血酶肽衍生物刺激骨生长
US6911425B2 (en) * 2000-08-16 2005-06-28 Acologix, Inc. Integrin binding motif containing peptides and methods of treating skeletal diseases

Also Published As

Publication number Publication date
US20070185010A1 (en) 2007-08-09
US20070184461A1 (en) 2007-08-09
CN1308677A (zh) 2001-08-15
US20080097082A1 (en) 2008-04-24
DE69935220D1 (de) 2007-04-05
AU765349B2 (en) 2003-09-18
US20080113428A1 (en) 2008-05-15
US7655760B2 (en) 2010-02-02
JP4424575B2 (ja) 2010-03-03
AU4362499A (en) 1999-12-06
EP1086225A2 (de) 2001-03-28
US7473771B2 (en) 2009-01-06
US20050014187A1 (en) 2005-01-20
CA2329054A1 (en) 1999-11-25
DE69935220T2 (de) 2007-11-15
ES2281964T3 (es) 2007-10-01
US7459300B2 (en) 2008-12-02
US7271151B2 (en) 2007-09-18
US6818745B1 (en) 2004-11-16
EP1086225B1 (de) 2007-02-21
DK1086225T3 (da) 2007-05-21
TWI227734B (en) 2005-02-11
CA2329054C (en) 2011-03-08
WO1999060017A3 (en) 2000-03-09
CN100359015C (zh) 2008-01-02
MXPA00011272A (es) 2003-04-22
WO1999060017A2 (en) 1999-11-25
JP2002515232A (ja) 2002-05-28

Similar Documents

Publication Publication Date Title
ATE354656T1 (de) Von menschlichem tumor stammendes polypeptidhormon phosphatonin
EP1082433A4 (de) Interleukine 21 und 22
WO2001058916A3 (en) Antibodies to ccr5
WO1998039446A3 (en) 70 human secreted proteins
WO1998039448A3 (en) 186 human secreted proteins
EP1053245A4 (de) 45 menschliche sekretierte proteine
WO1998040483A3 (en) 28 human secreted proteins
CY1111950T1 (el) 32 ανθρωπινες εκκρινομενες πρωτεϊνες
WO1998045712A3 (en) 20 human secreted proteins
DE69943022D1 (de) Der gemeinsamen gamma-kette ähnlicher zytokinrezeptor
WO2000017222A8 (en) 31 human secreted proteins
WO2000073323A3 (en) Adam polynucleotides and polypeptides
WO2001008635A3 (en) Calcium channel transport polynucleotides, polypeptides, and antibodies
EP1042342A4 (de) 53 proteine menschlichen ursprungs
MY127669A (en) Polypeptide hormone phosphatonin
UA72875C2 (uk) БІЛКИ, ЯКІ ЗВ'ЯЗУЮТЬСЯ З <font face="Symbol">b</font>-АМІЛОЇДНИМ ПЕПТИДОМ ТА ПОЛІНУКЛЕОТИДИ, ЩО ЇХ КОДУЮТЬ
WO2003083078A3 (en) Novel human cell surface protein with immunoglobulin folds, bgs-19
WO2004005487A3 (en) Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, bgs42
WO2003031586A3 (en) Acrp30-like polynucleotides, polypeptides, and antibodies
WO2000042165A3 (en) Bone marrow-specific protein
MY126634A (en) A novel polypeptide hormone phosphatonin
IL155687A0 (en) Polynucleotides encoding hlrrsi1 polypeptides
WO2000071567A3 (en) Fibroblast growth factor 13
WO2002028873A8 (en) Transcription factor polynucleotides, polypeptides, antibodies, and methods based thereon
EP1346999A3 (de) Humane sekretierte Proteine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1086225

Country of ref document: EP